LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. - Wikidata - wikimedia - TriplyDB

LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.

LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.

http://www.wikidata.org/entity/Q45982093

about

The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models.Polyphenol-rich bilberry ameliorates total cholesterol and LDL-cholesterol when implemented in the diet of Zucker diabetic fatty rats.Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion.Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule Hepatic fatty acid trafficking: multiple forks in the road Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling.n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.Egg consumption and insulin metabolism in the Insulin Resistance Atherosclerosis Study (IRAS).Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes

P2860

Q27022615-0542FB62-3F04-4134-99FA-5842B5E27E84 Q28258554-813800E0-5F15-48CD-A2E6-F1CB68503FF6 Q33858526-A2740F30-CA58-4A69-B616-A109B6571372 Q33863614-32915D8E-E52D-49D5-90F1-466F138BA606 Q34067485-23948251-B963-455D-B73F-286A28AE09AA Q34159251-D92CD9D9-6715-4027-B461-FC9F017EAB52 Q34565258-6FF9C5E9-95D9-46AC-B85C-1EE1726312DB Q35927759-C2984321-C58B-4083-9D2C-F08B5BF0A7F5 Q36896403-CF42F0DD-629C-48F2-9ED9-7010C18D7367 Q37296476-88F932FA-FE7C-421D-A980-21F91F3D51A7 Q37408615-5EEB9A38-BFC9-407A-B609-FC4B429D3FA3 Q38747596-86F697E8-9DF8-43B8-B952-DF91341676D8 Q39432694-9BD830BD-378F-4C0C-819D-C4AF41C1B236 Q39710752-07C6DAD1-9FAD-4688-BAC0-D58C51FCC598 Q41625507-1BA229B6-8DD0-4965-A5AD-14EA0F4F6578 Q45138556-D128F983-0F6E-4B3E-84AE-393347AB323F Q54494709-0D770D28-38D7-4DEE-AC32-20FF5D15A156 Q55425011-9B63E89D-9D05-45C6-AA45-53675A63C960 Q58778375-0B942E56-EE32-493D-8BC5-3E372C55D9EC

P2860

LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.

http://www.wikidata.org/entity/Q45982093

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@en

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@nl

type

label

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@en

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@nl

prefLabel

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@en

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@nl

P1433

Q45982093-D60F7240-D0EB-47FE-AD9D-AF34FE493BD5

P1476

Q45982093-5962495B-6DE0-4B5A-B502-CD3A078848CA

P2093

Q45982093-46FF73DE-8C80-45DC-81EE-4DB59C4A20BA

Q45982093-6FDD5200-FF04-4B4F-B35F-90A6EF22C207

Q45982093-9F8E9B17-1431-4219-BB0E-3C60F9766553

Q45982093-A831CD5A-405E-4E66-80E4-2E401E408DC8

Q45982093-C5101C3F-D161-4D02-BC12-3199A9CDFB21

P2860

Q45982093-05F54D99-F97A-4F99-8D1C-ADBF11AC1294

Q45982093-07EE1E36-A1A8-4A87-9A70-263BA502A479

Q45982093-0B502FC5-057F-442C-9443-970518EF6CF9

Q45982093-0CF881C3-837D-44DB-A539-4623C950F643

Q45982093-174A064D-267C-449C-87B8-5BBB1A66E1EE

Q45982093-1D2BA453-AB2C-4AA4-802E-37F4355CBFC9

Q45982093-1F0FB02A-F2C0-494F-B553-2CE2F4B374A5

Q45982093-21B47779-C39D-4DE2-B80D-7B836A66D0F3

Q45982093-22724931-7F2E-42B7-AEE7-D365937AAAB5

Q45982093-290BE774-F571-4340-B87A-FC9974AD6229

P304

Q45982093-941BC717-D5EF-4B7B-8E29-610BFBF6847C

P31

Q45982093-C95C4E5A-DB35-4FD3-905E-22FB4427F00B

P356

Q45982093-2EBFCCC8-3EED-4255-880E-3C25ACE5AE42

P433

Q45982093-3FE670FE-57AD-4B6D-AF53-CA04EAC2C929

P478

Q45982093-C0EEEEB4-C23A-4B60-97D7-CF66E68C71AC

P577

Q45982093-618B4946-52AA-49EF-B8CE-B3587EED84A0

P5875

Q45982093-D7283D75-552B-44D3-8AB2-02E4421A85D6

P698

Q45982093-56BDA581-BE0E-4A51-8867-0CD3DC0F77BA

P921

Q45982093-0DB079AF-FD6C-45AC-96A9-409ADF802F05

P356

AJPGI.90546.2008

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

LXRalpha activation perturbs h ...... ein B-containing lipoproteins.

@en

P2093

Abigale Miller

http://www.w3.org/2001/XMLSchema#string

Chris Baker

http://www.w3.org/2001/XMLSchema#string

Heather Basciano

http://www.w3.org/2001/XMLSchema#string

Khosrow Adeli

http://www.w3.org/2001/XMLSchema#string

Mark Naples

http://www.w3.org/2001/XMLSchema#string

P2860

Role of LXRs in control of lipogenesis

Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells

Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1

Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein

P304

G323-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.90546.2008

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26268178

http://www.w3.org/2001/XMLSchema#string

P698

19497957

http://www.w3.org/2001/XMLSchema#string

P921